C0001645||β-blockers
C0455825||left ventricular mass
C0020538||hypertension
C0026348||Bayesian network
C0920317||meta-analysis
C0149721||Left ventricular hypertrophy
C0149721||Left ventricular hypertrophy
C0020538||hypertension
C0020538||hypertension
C1301746||expert consensus document
C0596070||American
C0003015||angiotensin-converting enzyme inhibitor
C0003015||angiotensin-converting enzyme inhibitor
C0815017||angiotensin receptor blockers
C0815017||angiotensin receptor blockers
C0013227||therapeutic drugs
C0304516||fat-soluble and selective β1-receptor blockers
C0304516||fat-soluble and selective β1-receptor blockers
C0001645||β-blockers
C0149721||Left ventricular hypertrophy
C0920317||analysis
C0304516||fat-soluble and selective β1-receptor blockers
C0003364||antihypertensive drugs
C0003015||angiotensin-converting enzyme inhibitor
C0815017||angiotensin receptor blockers
C0006684||calcium channel blockers
C0006684||calcium channel blockers
C0012798||diuretics
C0149721||Left ventricular hypertrophy
C0008976||trials
C1138432||PubMed
C2349146||Web of Science
C0282443||OVID EBM Reviews
C0242356||Cochrane databases
C1706852||papers
C0026348||Bayesian
C0920317||meta-analysis
C0206035||randomized controlled trials
C0206035||randomized controlled trials
C0149721||Left ventricular hypertrophy
C0936012||Sensitivity analysis
C0034980||regression analysis
C0936012||Inconsistency analysis
C0920317||analysis
C0008976||trials
C0026348||network
C0206035||randomized controlled trials
C0020538||hypertension
C0149721||Left ventricular hypertrophy
C0920317||analysis
C0026348||Bayesian network
C0920317||meta-analysis
C0304516||fat-soluble and selective β1-receptor blockers
C0003015||angiotensin-converting enzyme inhibitor
C0304516||fat-soluble and selective β1-receptor blockers
C0815017||ARB
C0304516||fat-soluble and selective β1-receptor blockers
C0012798||diuretic
C0006684||CCB
C0087111||treatments
C0304516||fat-soluble and selective β1-receptor blockers
C0815017||ARB
C0003015||angiotensin-converting enzyme inhibitor
C0006684||CCB
C0012798||diuretic
C0920317||analysis
C0304516||fat-soluble and selective β1-receptor blockers
C0013227||therapeutic drugs
C0020538||hypertension
C0149721||Left ventricular hypertrophy
C0304516||fat-soluble and selective β1-receptor blockers
C0149721||Left ventricular hypertrophy
C0008976||trials